Laboratorios Richmond S.A.C.I.F.

BASE:RICHD Stock Report

Market Cap: US$138.0m

Laboratorios RichmondC.I.F Balance Sheet Health

Financial Health criteria checks 2/6

Laboratorios RichmondC.I.F has a total shareholder equity of ARS61.0B and total debt of ARS136.4B, which brings its debt-to-equity ratio to 223.8%. Its total assets and total liabilities are ARS248.0B and ARS187.0B respectively. Laboratorios RichmondC.I.F's EBIT is ARS13.0B making its interest coverage ratio -27.6. It has cash and short-term investments of ARS9.3B.

Key information

223.8%

Debt to equity ratio

AR$136.44b

Debt

Interest coverage ratio-27.6x
CashAR$9.31b
EquityAR$60.97b
Total liabilitiesAR$187.00b
Total assetsAR$247.97b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: RICHD's short term assets (ARS57.7B) exceed its short term liabilities (ARS46.8B).

Long Term Liabilities: RICHD's short term assets (ARS57.7B) do not cover its long term liabilities (ARS140.2B).


Debt to Equity History and Analysis

Debt Level: RICHD's net debt to equity ratio (208.5%) is considered high.

Reducing Debt: RICHD's debt to equity ratio has increased from 38.4% to 223.8% over the past 5 years.

Debt Coverage: RICHD's debt is not well covered by operating cash flow (6%).

Interest Coverage: RICHD earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies